Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-25-102037
Filing Date
2025-10-24
Accepted
2025-10-24 11:00:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 18075
2 EXHIBIT 99.1 tm2529387d1_ex99-1.htm EX-99.1 10102
3 EXHIBIT 99.2 tm2529387d1_ex99-2.htm EX-99.2 4608
4 EXHIBIT 99.3 tm2529387d1_ex99-3.htm EX-99.3 36255
  Complete submission text file 0001104659-25-102037.txt   70857
Mailing Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201
Business Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201 (847)905-4400
Magnetar Financial LLC (Filed by) CIK: 0001352851 (see all company filings)

EIN.: 043818748 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D

Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-88910 | Film No.: 251415049
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)